Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Commodities
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Context Therapeutics Inc
CNTX
Healthcare
Context Therapeutics Inc. is a biopharmaceutical company focused on improving the lives of patients living with solid tumors. The Company is developing CTIM-76, a selective Claudin 6 (CLDN6) x CD3 bispecific antibody for CLDN6-positive tumors. Its preclinical program, CTIM-76, is an anti-Claudin 6 x anti-CD3 (CLDN6xCD3) antigen bispecific monoclonal antibody (bsAb) that is intended to redirect...
T-cell-mediated lysis toward malignant cells expressing CLDN6. CLDN6 is a tight junction membrane protein target expressed in multiple solid tumors, including ovarian, lung, and testicular, and absent from or expressed at low levels in healthy adult tissues. CTIM-76 is a Claudin 6 and CD3 bispecific antibody capable of binding to tumor cells expressing Claudin 6 and stimulating intra-tumoral T cells by the CD3 arm that is designed to be activated only upon tumor engagement. Claudin 6 is expressed on multiple solid tumors such as ovarian, lung and testicular.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:CNTX)
New Post
View:
Posts & Comments
Threaded Posts
(0)
•••
PressRelease
X
Post by
PressRelease
on Feb 06, 2023 7:30am
New Press Release - Context Therapeutics Highlights Clinical Responses from the Phase 2 OATH Clinical Trial Evaluating ONA-XR for the Treatment of Endometrial Cancer
ONA-XR initial data signals positive clinical activity and confirmed tumor shrinkage ONA-XR continues to be safe and well-toleratedPHILADELPHIA, Feb. 06, 2023 (GLOBE NEWSWIRE) -- Context Therapeutics Inc. (“Context” or the “Company”) (Nasdaq: CNTX), a company developing novel treatments for...
read article.
(62)
•••
Iseneschal
X
Comment by
Iseneschal
on Feb 02, 2023 11:59am
RE:CNTX...... mini pop to $1.15
SILO....... pop....now $3.65 Shoulda coulda
GMV Minerals Receives Helicopter-Borne High Resolution Magnetic and Radiometric Survey Results
posted Nov 29, 2023 9:00am by
GMV Minerals Inc
-
|
The Company is pleased to announce that it has received the completed geophysical surveys from Precision GeoSurveys Inc. of Langley, British Columbia on its Daisy Creek project in Lander County, Nevada. Ian Klassen, CEO remarked, "We are very pleased with the results of this survey. We know that high-grade lithium assays (up to 20,000 ppm Li) came from a uranium exploration program, and that the ...read more
(62)
•••
Iseneschal
X
Post by
Iseneschal
on Jan 31, 2023 3:42pm
CNTX...... mini pop to $1.15
I like to leave some for the next guy ; ) Cheers............oh....take a look at SILO on NASDAQ...share buyback! $2.75 u.s
(62)
•••
Iseneschal
X
Post by
Iseneschal
on Jan 31, 2023 3:22pm
CNTX ....still climbing the RBL
$1.10 Me ...no position ; )
(62)
•••
Iseneschal
X
Post by
Iseneschal
on Jan 31, 2023 3:03pm
CNTX.... vols are increasing and so is the
Share price On watch
(62)
•••
Iseneschal
X
Post by
Iseneschal
on Jan 31, 2023 2:30pm
CNTX..... Is that the low or ???
97 pesos ; )
(62)
•••
Iseneschal
X
Post by
Iseneschal
on Jan 31, 2023 10:48am
CNTX ....outside chance here at $1.15 for a bounce
Was in PB mode ....has since switched to "sideways" mode Range bound....check ur charts in the 5 min
(62)
•••
Iseneschal
X
Post by
Iseneschal
on Jan 31, 2023 10:17am
CNTX ....early am runner in PB mode
You'd be a spearcatcher now Done
(6)
•••
Shanemorg58
X
Post by
Shanemorg58
on Jan 06, 2023 11:10am
Strong Hold!
https://www.edisongroup.com/publication/a-catalyst-rich-period-ahead/31836/ the company is making really good progress in advancing both of its pipeline assets, and not to mention presenting
...more
(6)
•••
Shanemorg58
X
Post by
Shanemorg58
on May 13, 2022 9:23am
Awesome webinar!
https://twitter.com/Context_Tx/status/1525083585610383360 Check out this awesome R&D Webinar! Big things coming for CNTX!
(6)
•••
Shanemorg58
X
Post by
Shanemorg58
on May 05, 2022 10:02am
Huge potential
https://www.biospace.com/article/context-therapeutics-is-targeting-progesterone-to-outsmart-tumors-in-women-s-cancers-/ wow Context therapeutics is targeting progesterone receptors to help ensure
...more
(6)
•••
Shanemorg58
X
Post by
Shanemorg58
on Apr 22, 2022 10:26am
Strong Hold!
https://www.americanbankingnews.com/2022/04/22/context-therapeutics-nasdaqcntx-stock-rating-upgraded-by-zacks-investment-research.html Upgraded to a strong hold! LFGG!
(62)
•••
Iseneschal
X
Post by
Iseneschal
on Dec 10, 2021 12:04pm
CNTX ..... What an implosion !!!!!
I knew it ....didn't like it from the start !!
(62)
•••
Iseneschal
X
Post by
Iseneschal
on Dec 10, 2021 8:37am
CNTX ....early a.m runner on NR
Make note: IPO'd last Oct at $5........ the a P.P at $6.25 Dec 01 Trade accordingly Cheers !
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
AI Beyond Hype: Real-world Applications and Possibilities
Want to know which Canadian silver exchange traded funds on the Toronto Stock Exchange are the best?
Stunning Drill Results at Historic Copper Mine in Ontario with 14.8% Copper over 2.45 Metres
Pulsar Helium to Present and Host Open Q&A at the Emerging Growth Conference Dec. 7 – Register Now